Solara Active Pharma Sciences informs about proposed incorporation of WOS

07 Feb 2025 Evaluate

With reference to earlier letter dated January 24, 2025 whereby the Company had informed the stock exchanges about granting of in-principle approval for proposed demerger of the CRAMS and Polymers Business into an Independent Listed Entity, by the Board of Directors of the Company; and in continuation thereof and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), as amended, Solara Active Pharma Sciences has informed that the Board Committee of the Company at its meeting held today, i.e., February 7, 2025, has approved incorporation of a Wholly-owned Subsidiary of the Company. The details required under Regulation 30 of the SEBI Listing Regulations, read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 and SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, with respect to the above incorporation of a Wholly-owned Subsidiary is given in Annexure enclosed. The meeting of the Board Committee of the Company commenced at 10:00 am and concluded at 10:20 am.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Share Price

527.60 -25.30 (-4.58%)
25-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1766.00
Dr. Reddys Lab 1180.55
Cipla 1510.65
Lupin 2068.70
Zydus Lifesciences 907.45
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...